251 related articles for article (PubMed ID: 17052812)
1. Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy.
Minigo G; Scholzen A; Tang CK; Hanley JC; Kalkanidis M; Pietersz GA; Apostolopoulos V; Plebanski M
Vaccine; 2007 Jan; 25(7):1316-27. PubMed ID: 17052812
[TBL] [Abstract][Full Text] [Related]
2. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
Wang X; Uto T; Akagi T; Akashi M; Baba M
J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
[TBL] [Abstract][Full Text] [Related]
4. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice.
Jiang L; Qian F; He X; Wang F; Ren D; He Y; Li K; Sun S; Yin C
J Gene Med; 2007 Apr; 9(4):253-64. PubMed ID: 17397104
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine.
Marshall DJ; Rudnick KA; McCarthy SG; Mateo LR; Harris MC; McCauley C; Snyder LA
Vaccine; 2006 Jan; 24(3):244-53. PubMed ID: 16135392
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice.
Hattori Y; Kawakami S; Suzuki S; Yamashita F; Hashida M
Biochem Biophys Res Commun; 2004 May; 317(4):992-9. PubMed ID: 15094367
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
[TBL] [Abstract][Full Text] [Related]
8. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.
Chong SY; Egan MA; Kutzler MA; Megati S; Masood A; Roopchard V; Garcia-Hand D; Montefiori DC; Quiroz J; Rosati M; Schadeck EB; Boyer JD; Pavlakis GN; Weiner DB; Sidhu M; Eldridge JH; Israel ZR
Vaccine; 2007 Jun; 25(26):4967-82. PubMed ID: 17335943
[TBL] [Abstract][Full Text] [Related]
9. Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives.
Akagi T; Wang X; Uto T; Baba M; Akashi M
Biomaterials; 2007 Aug; 28(23):3427-36. PubMed ID: 17482261
[TBL] [Abstract][Full Text] [Related]
10. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation.
Roos AK; Moreno S; Leder C; Pavlenko M; King A; Pisa P
Mol Ther; 2006 Feb; 13(2):320-7. PubMed ID: 16185933
[TBL] [Abstract][Full Text] [Related]
12. Chemical adjuvants for plasmid DNA vaccines.
Greenland JR; Letvin NL
Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
[TBL] [Abstract][Full Text] [Related]
13. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
Loeffler DI; Schoen CU; Goebel W; Pilgrim S
Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
[TBL] [Abstract][Full Text] [Related]
14. Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity.
Kalkanidis M; Pietersz GA; Xiang SD; Mottram PL; Crimeen-Irwin B; Ardipradja K; Plebanski M
Methods; 2006 Sep; 40(1):20-9. PubMed ID: 16997710
[TBL] [Abstract][Full Text] [Related]
15. Generic construction of single component particles that elicit humoural and cellular immune responses without the need for adjuvants.
White PJ; Anastasopoulos F; Church JE; Kuo CY; Boyd BJ; Hickey PL; Tu LS; Burns P; Lew AM; Heath WR; Davey GM; Pouton CW
Vaccine; 2008 Dec; 26(52):6824-31. PubMed ID: 18948160
[TBL] [Abstract][Full Text] [Related]
16. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
Hao S; Yuan J; Xiang J
J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
[TBL] [Abstract][Full Text] [Related]
17. TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.
Tudor D; Dubuquoy C; Gaboriau V; Lefèvre F; Charley B; Riffault S
Vaccine; 2005 Jan; 23(10):1258-64. PubMed ID: 15652668
[TBL] [Abstract][Full Text] [Related]
18. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration.
Hattori Y; Kawakami S; Lu Y; Nakamura K; Yamashita F; Hashida M
J Gene Med; 2006 Jul; 8(7):824-34. PubMed ID: 16625665
[TBL] [Abstract][Full Text] [Related]
19. Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells.
Ma K; Xu W; Shao X; Yanyue ; Hu L; Xu H; Yuan Z; Zheng X; Xiong S
Antiviral Res; 2007 Nov; 76(2):140-9. PubMed ID: 17655942
[TBL] [Abstract][Full Text] [Related]
20. [Immune response and protective efficacy in BALB/c mice induced by DNA vaccine encoding immunogenic protein of Legionella pneumophila].
Yang ZW; Chen JP; Wang T; Tian Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Mar; 23(3):209-12. PubMed ID: 17343784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]